                         SEQUENCE LISTING

<110>  The Regents of the University of Colorado, a body corporate
       Xue, Ding
       Geng, Xin
 
<120>  COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B

<130>  CU-008210PC

<150>  61/706,083
<151>  2012-09-26

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptaibol Trichokonin VI


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Acetylated 2-aminoisobutyricacid attached alanine

<220>
<221>  MISC_FEATURE
<222>  (2)..(3)
<223>  2-aminoisobutyricacid attached alanine

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  2-aminoisobutyricacid attached valine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  2-aminoisobutyricacid attached glycine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  2-aminoisobutyricacid attached Proline

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  di-(2-aminoisobutyricacid) attached Glutamine

<400>  1

Xaa Xaa Xaa Gln Xaa Xaa Leu Pro Val Xaa Gln Phe 
1               5                   10          


<210>  2
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptaibol Trichokonin VII


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Acetylated 2-amininoisobutyric acid attached alanine

<220>
<221>  MISC_FEATURE
<222>  (2)..(3)
<223>  2-amininoisobutyric acid attached alanine

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  2-amininoisobutyric acid attached Valine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  2-amininoisobutyric acid attached Glycine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  2-amininoisobutyric acid attached Proline

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  2-amininoisobutyric acid attached isovaleric acid

<400>  2

Xaa Xaa Xaa Gln Val Gly Leu Pro Val Xaa Gln Phe 
1               5                   10          


<210>  3
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptaibol Trichokonin VIII


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Acetylated 2-aminoisobutyric acid attached alanine

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  2-aminoisobutyric acid attached alanine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  di(2-aminoisobutyric acid) attached glutamine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  2-aminoisobutyric acid substituted valine

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  2-aminoisobutyric acid substituted glycine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  2-aminoisobutyric acid substituted proline

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  di(2-aminoisobutyric acid) substituted glutamine

<400>  3

Xaa Xaa Xaa Xaa Xaa Leu Xaa Val Xaa Gln Phe 
1               5                   10      


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer set 1 for HBS

<400>  4
gtgtctgcgg cgttttatca                                                   20


<210>  5
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer Set 1 for HBS

<400>  5
gacaaacggg caacatacct t                                                 21


<210>  6
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer set for polymerase

<400>  6
tactagtgcc atttgttcag tgg                                               23


<210>  7
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer set for polymerase

<400>  7
cacgatgctg tacagacttg g                                                 21


<210>  8
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  mRNA Sequence of Bcl-2 targeted by shRNA

<400>  8
ccgggagata gtgatgaagt a                                                 21


<210>  9
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Bcl-xL mRNA targeted by shRNA

<400>  9
gtggaactct atgggaacaa t                                                 21


